Increased CD160 expression on circulating natural killer cells in atherogenesis
Open Access
- 13 June 2015
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 13 (1) , 1-9
Abstract
Atherosclerosis (AS) presents characteristic of a chronic inflammatory disease in which both adaptive and innate immune cells play roles. Accumulating evidence has showed the impairment of natural killer (NK) cells in atherosclerosis, however, the mechanisms of this impairment remain unclear. In this study, we investigated the expression of CD160 on NK cells and assessed its pathological roles in NK loss during atherogenesis. CD160 expression on NK cells was measured in 49 AS patients and 41 healthy controls (HC) by flow cytometry, their inflammatory cytokine levels in sera were determined by ELSIA, and the effect of CD160 engagement on NK cells was evaluated by in vitro culture experiments. Compared to HC, AS patients had a significantly increased CD160 expression on peripheral NK cells and concomitantly decreased peripheral NK cell number, and increased CD160 expression was positively related to the levels of serum lipids and IFN-γ, TNF-α and IL-6 inflammation cytokines, which all are risk factors for atherogenesis, and inversely correlated with peripheral NK cell number. Furthermore, engagement of CD160 receptor on NK cells from AS patients triggers a significantly increased production of inflammation cytokines and subsequent NK cell apoptosis, and blockade of TNF-α prevented the increased apoptosis of NK cells from AS patients after CD160 engagement, indicating a critical role of TNF-α in mediating NK cell loss by CD160 engagement. Our results provide evidence that elevated CD160 expression on NK cells plays an important role in NK cell loss in atherosclerosis. The increased CD160 expression on NK cells might be used as an indicator for disease progression.Keywords
This publication has 37 references indexed in Scilit:
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal CarcinomaPLOS ONE, 2013
- Hyperlipidaemia and cardiovascular disease: inflammation and oxidative stress in diabetic patientsCurrent Opinion in Lipidology, 2009
- Inflammatory Biomarkers in Stable AtherosclerosisThe American Journal of Cardiology, 2006
- Microvascular Responses to Hypercholesterolemia: The Interactions Between Innate and Adaptive Immune ResponsesAntioxidants & Redox Signaling, 2006
- Loss of natural killer cell activity in patients with coronary artery diseaseAtherosclerosis, 2005
- Identification of natural killer cells in human atherosclerotic plaqueAtherosclerosis, 2005
- Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interactionBlood, 2002
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.Journal of Experimental Medicine, 1993